Monogram Orthopaedics Inc MGRM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MGRM is a good fit for your portfolio.
News
-
Monogram Provides Regulatory Update Following Meeting with FDA
-
Monogram Accepted to NVIDIA Inception Program
-
Monogram Orthopaedics to Host Business Update Conference Call on Thursday, March 21st at 5:00 p.m. Eastern Time
-
Monogram Orthopaedics Reports Full Year 2023 Financial Results
-
Monogram Orthopaedics to Present Rescheduled Product Discussion with Surgeon Reaction during AAOS Annual Meeting
Trading Information
- Previous Close Price
- $1.95
- Day Range
- $1.84–2.01
- 52-Week Range
- $1.53–48.99
- Bid/Ask
- $1.85 / $2.10
- Market Cap
- $59.52 Mil
- Volume/Avg
- 156,029 / 234,641
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 120.33
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Monogram Orthopaedics Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- —
- Total Number of Employees
- 28
Comparables
Valuation
|
Metric
|
MGRM
|
RBOT
|
688277
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 4.58 | 0.61 | 3.33 |
Price/Sales | 120.33 | — | 21.29 |
Price/Cash Flow | — | — | — |
Price/Earnings
MGRM
RBOT
688277
Financial Strength
|
Metric
|
MGRM
|
RBOT
|
688277
|
|---|---|---|---|
Quick Ratio | 4.95 | 16.57 | 4.58 |
Current Ratio | 5.19 | 17.16 | 5.49 |
Interest Coverage | — | −2,710.71 | −26.73 |
Quick Ratio
MGRM
RBOT
688277
Profitability
|
Metric
|
MGRM
|
RBOT
|
688277
|
|---|---|---|---|
Return on Assets (Normalized) | −95.70% | −49.29% | −13.33% |
Return on Equity (Normalized) | −180.11% | −63.37% | −16.46% |
Return on Invested Capital (Normalized) | −173.85% | −58.04% | −14.25% |
Return on Assets
MGRM
RBOT
688277
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Byymffgm | Mpxsh | $182.6 Bil | |
SYK
| Stryker Corp | Ghmqqgddk | Yryj | $125.9 Bil | |
MDT
| Medtronic PLC | Hyzdfbd | Jhdphz | $108.3 Bil | |
BSX
| Boston Scientific Corp | Kqcnlqhlp | Gmbnfy | $106.9 Bil | |
EW
| Edwards Lifesciences Corp | Vqwmdcrs | Qjlxjn | $52.3 Bil | |
DXCM
| DexCom Inc | Tyjnhcvcf | Gbj | $50.3 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Dndfmxnzk | Ypfkv | $25.0 Bil | |
PHG
| Koninklijke Philips NV ADR | Qzlzhxnq | Ygkqms | $24.3 Bil | |
ALGN
| Align Technology Inc | Mjlsbtd | Gqbqns | $21.1 Bil | |
PODD
| Insulet Corp | Ndzfnpbx | Vhmjwm | $12.4 Bil |